Table 3.

Outcomes in hypofractionated and conventional arms after a median follow up of 51 and 53 months respectively

	Total n (%)	Hypofractionated	Conventional	p-value
nPSA ≤ 0.5 ng/mL	159 (94.6%)	82 (97.6%)	77 (91.7%)	0.0814
3 year bNED	134 (79.8%)	73 (86.9%)	61 (72.6%)	0.0235
Biochemical failure	23 (13.7%)	09 (10.7%)	14 (16.7%)	0.2634
Local recurrence	06 (3.6%)	02 (2.4%)	04 (4.8%)	0.4126
Metastases	12 (7.1%)	05 (5.9%)	07 (8.3%)	0.5512
Death from other causes	05 (2.9%)	02 (2.4%)	03 (3.6%)	0.6454
Death from tumor	03 (1.8%)	01 (1.2%)	02 (2.4%)	0.5663

nPSA — nadir prostate specific antigen; bNED — biochemical no evidence of disease